GOLDMAN SACHS GROUP INC - TG THERAPEUTICS INC ownership

TG THERAPEUTICS INC's ticker is TGTX and the CUSIP is 88322Q108. A total of 252 filers reported holding TG THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.81 and the average weighting 0.3%.

Quarter-by-quarter ownership
GOLDMAN SACHS GROUP INC ownership history of TG THERAPEUTICS INC
ValueSharesWeighting
Q2 2024$37,086,954
+89.5%
2,084,708
+62.1%
0.01%
+100.0%
Q1 2024$19,566,570
-30.6%
1,286,428
-22.0%
0.00%
-40.0%
Q4 2023$28,179,217
+99.3%
1,649,837
-2.4%
0.01%
+66.7%
Q3 2023$14,136,342
-60.0%
1,690,950
+19.0%
0.00%
-62.5%
Q2 2023$35,306,831
+100.7%
1,421,370
+21.5%
0.01%
+100.0%
Q1 2023$17,589,310
+22.3%
1,169,502
-3.8%
0.00%0.0%
Q4 2022$14,380,087
+157438.2%
1,215,561
-21.2%
0.00%
+100.0%
Q3 2022$9,128
+124.9%
1,541,921
+61.5%
0.00%
+100.0%
Q2 2022$4,058
-100.0%
954,679
-28.3%
0.00%
-66.7%
Q1 2022$12,671,000
-40.2%
1,332,402
+19.5%
0.00%
-25.0%
Q4 2021$21,186,000
-42.4%
1,115,066
+0.8%
0.00%
-50.0%
Q3 2021$36,804,000
+34.0%
1,105,875
+56.2%
0.01%
+33.3%
Q2 2021$27,462,000
-57.1%
707,981
-46.7%
0.01%
-62.5%
Q1 2021$64,076,000
+0.4%
1,329,380
+8.4%
0.02%0.0%
Q4 2020$63,798,000
+86.7%
1,226,427
-4.0%
0.02%
+60.0%
Q3 2020$34,173,000
+55.9%
1,277,025
+13.5%
0.01%
+42.9%
Q2 2020$21,923,000
+95.5%
1,125,399
-1.3%
0.01%
+75.0%
Q1 2020$11,216,000
-17.2%
1,139,875
-6.6%
0.00%
+33.3%
Q4 2019$13,548,000
+128.3%
1,220,522
+15.5%
0.00%
+50.0%
Q3 2019$5,934,000
-26.5%
1,056,753
+13.2%
0.00%0.0%
Q2 2019$8,075,000
+6.8%
933,502
-0.8%
0.00%0.0%
Q1 2019$7,562,000
+141.8%
940,656
+23.4%
0.00%
+100.0%
Q4 2018$3,127,000
+47.6%
762,585
+101.6%
0.00%0.0%
Q3 2018$2,119,000
-55.6%
378,311
+4.2%
0.00%0.0%
Q2 2018$4,776,000
-18.8%
363,181
-12.3%
0.00%0.0%
Q1 2018$5,880,000
+130.0%
414,128
+32.8%
0.00%0.0%
Q4 2017$2,557,000
+894.9%
311,793
+1335.0%
0.00%
Q3 2017$257,000
-48.7%
21,727
-49.5%
0.00%
Q1 2017$501,000
+534.2%
43,020
+152.8%
0.00%
Q4 2016$79,000
-11.2%
17,019
+48.8%
0.00%
Q3 2016$89,000
-87.5%
11,439
-73.4%
0.00%
Q2 2015$714,000
+80.3%
43,053
+68.5%
0.00%
Q1 2015$396,000
+308.2%
25,552
+148.5%
0.00%
Q2 2014$97,000
-86.6%
10,282
-90.9%
0.00%
Q2 2013$724,000113,2990.00%
Other shareholders
TG THERAPEUTICS INC shareholders Q2 2023
NameSharesValueWeighting ↓
Jetstream Capital LLC 200,000$7,758,0005.97%
Lion Point Capital, LP 609,128$23,628,0004.08%
RA Capital Management 3,342,743$129,665,0002.08%
Ghost Tree Capital, LLC 180,000$6,982,0001.92%
Nicholas Investment Partners, LP 660,964$25,639,0001.61%
ARDSLEY ADVISORY PARTNERS LP 350,000$13,577,0001.60%
SECTORAL ASSET MANAGEMENT INC 414,949$16,096,0001.30%
Spotlight Asset Group, Inc. 75,000$2,909,0001.12%
ACT CAPITAL MANAGEMENT, LLC 55,000$2,134,0001.10%
Pier Capital, LLC 280,486$10,880,0001.09%
View complete list of TG THERAPEUTICS INC shareholders